Replimune Group Inc (REPL) Stock Forecast & Price Target
Replimune Group Inc · NASDAQ
$8.63-1.06 (-10.98%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering Replimune Group Inc, 1 rate it Buy or better, 5 sit at Hold, and 2 rate it Sell or worse, a hold consensus. The target range is very wide, $2.00 to $14.00 (about 7.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $8.71 sits 1% above the current $8.63. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.56 next quarter toward $-1.15 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Hold
Strong Buy00%
Buy113%
Hold563%
Sell225%
Strong Sell00%
Based on 8 analysts giving stock ratings to Replimune Group Inc.
As of Jul, 1 of 8 firms rate REPL a Buy (5 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
REPL EPS & revenue forecast
EPS · NEXT QUARTER
$-0.56
Range $-0.57 – $-0.54 · 2 analysts · -38% YoY
Next period, 2 analysts expect Replimune Group Inc to earn $-0.56 a share (range $-0.57 – $-0.54), versus $-0.90 a year earlier. Full-year consensus is $-1.94, growing to $-1.15 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 2 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $33.5M, rising to $69.9M next year.
Top analysts covering Replimune Group Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on REPL.
#1
Anupam Rama
JP Morgan · Rank #62
Sell
No targeton REPL
Overall win rate
46%
+ Follow
#2
RB
Robert Burns
HC Wainwright & Co. · Rank #195
Sell
No targeton REPL
Overall win rate
38%
+ Follow
#3
Li Watsek
Cantor Fitzgerald · Rank #218
Hold
No targeton REPL
Overall win rate
38%
+ Follow
#4
Robert Driscoll
Wedbush · Rank #313
Hold
$9.00+4.2% to target
Overall win rate
30%
+ Follow
#5
Jonathan Chang
Leerink Partners
Hold
$2.00-76.8% to target
Coverage
—
+ Follow
REPL stock forecast FAQ
What is REPL's average 12-month price target?+
The 5 analysts with a live target average $8.71 for Replimune Group Inc over the next 12 months, ranging from a $14.00 high to a $2.00 low.
Is REPL stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 8 analyst ratings, 1 are Buy or Strong Buy, 5 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for REPL?+
The Street-high target is $14.00 (Piper Sandler), and the Street-low is $2.00 (Leerink Partners). The average of all 5 active targets is $8.71.
How many Wall Street analysts cover REPL?+
8 analysts have an active rating on Replimune Group Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering REPL?+
Among analysts who currently cover REPL, Anupam Rama of JP Morgan has the strongest overall Quantellect track record (Rank #62). Their current call is Sell.
What is Replimune Group Inc's projected EPS for next quarter?+
The consensus estimate is $-0.56 per share (range $-0.57 – $-0.54) across 2 analysts. Full-year EPS is projected at $-1.94, rising to $-1.15 the following year.
How much revenue is Replimune Group Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $33.5M, growing to $69.9M next year.
Have analysts been upgrading or downgrading REPL lately?+
As of Jul, 1 of 8 firms rate REPL a Buy (5 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their REPL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
